These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20393007)

  • 1. Phellodendron amurense bark extract prevents progression of prostate tumors in transgenic adenocarcinoma of mouse prostate: potential for prostate cancer management.
    Ghosh R; Graham H; Rivas P; Tan XJ; Crosby K; Bhaskaran S; Schoolfield J; Banu J; Fernandes G; Yeh IT; Kumar AP
    Anticancer Res; 2010 Mar; 30(3):857-65. PubMed ID: 20393007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract.
    Kumar AP; Bhaskaran S; Ganapathy M; Crosby K; Davis MD; Kochunov P; Schoolfield J; Yeh IT; Troyer DA; Ghosh R
    Clin Cancer Res; 2007 May; 13(9):2784-94. PubMed ID: 17473212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
    Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen-independent prostate cancer progression in the TRAMP model.
    Gingrich JR; Barrios RJ; Kattan MW; Nahm HS; Finegold MJ; Greenberg NM
    Cancer Res; 1997 Nov; 57(21):4687-91. PubMed ID: 9354422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA; Narayanan NK; Pittman B; Reddy BS
    Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition.
    Narayanan BA; Narayanan NK; Pttman B; Reddy BS
    Prostate; 2006 Feb; 66(3):257-65. PubMed ID: 16175586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer.
    Adhami VM; Siddiqui IA; Ahmad N; Gupta S; Mukhtar H
    Cancer Res; 2004 Dec; 64(23):8715-22. PubMed ID: 15574782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2 accelerates multistep prostate carcinogenesis in vivo.
    Bruckheimer EM; Brisbay S; Johnson DJ; Gingrich JR; Greenberg N; McDonnell TJ
    Oncogene; 2000 Nov; 19(46):5251-8. PubMed ID: 11077442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.
    Wu GJ; Fu P; Chiang CF; Huss WJ; Greenberg NM; Wu MW
    J Urol; 2005 May; 173(5):1778-83. PubMed ID: 15821586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear matrix localization of high mobility group protein I(Y) in a transgenic mouse model for prostate cancer.
    Leman ES; Madigan MC; Brünagel G; Takaha N; Coffey DS; Getzenberg RH
    J Cell Biochem; 2003 Feb; 88(3):599-608. PubMed ID: 12532335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butanol fraction containing berberine or related compound from nexrutine inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells.
    Muralimanoharan SB; Kunnumakkara AB; Shylesh B; Kulkarni KH; Haiyan X; Ming H; Aggarwal BB; Rita G; Kumar AP
    Prostate; 2009 Apr; 69(5):494-504. PubMed ID: 19107816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice.
    Raina K; Singh RP; Agarwal R; Agarwal C
    Cancer Res; 2007 Jun; 67(12):5976-82. PubMed ID: 17575168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model.
    Foster BA; Gingrich JR; Kwon ED; Madias C; Greenberg NM
    Cancer Res; 1997 Aug; 57(16):3325-30. PubMed ID: 9269988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase-dependent apoptosis induction by phenethyl isothiocyanate, a cruciferous vegetable-derived cancer chemopreventive agent, is mediated by Bak and Bax.
    Xiao D; Zeng Y; Choi S; Lew KL; Nelson JB; Singh SV
    Clin Cancer Res; 2005 Apr; 11(7):2670-9. PubMed ID: 15814648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: role of tumor necrosis factor-alpha-stimulated gene 6.
    Garcia GE; Wisniewski HG; Lucia MS; Arevalo N; Slaga TJ; Kraft SL; Strange R; Kumar AP
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):980-8. PubMed ID: 16467113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer progression, metastasis, and gene expression in transgenic mice.
    Perez-Stable C; Altman NH; Mehta PP; Deftos LJ; Roos BA
    Cancer Res; 1997 Mar; 57(5):900-6. PubMed ID: 9041192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model.
    Hsieh CL; Xie Z; Yu J; Martin WD; Datta MW; Wu GJ; Chung LW
    Prostate; 2007 May; 67(7):685-91. PubMed ID: 17342752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
    Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model.
    Raghow S; Kuliyev E; Steakley M; Greenberg N; Steiner MS
    Cancer Res; 2000 Aug; 60(15):4093-7. PubMed ID: 10945615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model.
    Pflug BR; Pecher SM; Brink AW; Nelson JB; Foster BA
    Prostate; 2003 Nov; 57(3):245-54. PubMed ID: 14518031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.